Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis

Medical Microbiology and Immunology

Volumn 203, Issue 5, 2014, Pages 315-322

  Torres Morales, Elizabeth ^a   Taborda, Laura ^a   Cardona, Nestor ^a   De la Torre, Alejandra ^a,b   Sepulveda Arias, Juan Carlos ^c   Patarroyo, Manuel Alfonso ^b,d   Gomez Marin, Jorge Enrique ^a  

^a UNIVERSIDAD DEL QUINDÍO   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^d FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

Author keywords

IL10; Interferon gamma; P30 protein; Peptides; ROP18; Th1; Th2; Toxoplasma; Vaccine

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; PROTEIN P30; ROP18 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR; CYTOKINE; LEUKOCYTE ANTIGEN; PARASITE ANTIGEN; PROTEIN SERINE THREONINE KINASE; PROTOZOAL PROTEIN; ROP18 PROTEIN, TOXOPLASMA GONDII; SAG1 ANTIGEN, TOXOPLASMA;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; ASYMPTOMATIC DISEASE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; NONHUMAN; PARASITE VIRULENCE; TH1 CELL; TH2 CELL; TOXOPLASMOSIS; ADOLESCENT; CELL PROLIFERATION; CHEMISTRY; FLOW CYTOMETRY; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; SECRETION (PROCESS); T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; PROTOZOAN PROTEINS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TOXOPLASMOSIS; YOUNG ADULT;

EID: 84919477257     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-014-0339-0     Document Type: Article

References (26)

1. Gómez-Marin JE (2010) Toxoplasmosis. In: Gomez-Marin JE. Protozoologia médica: Protozoos parásitos en el contexto latinoamericano, 1st ed. Editorial Manual Moderno, Bogotá, p 65
2. Robertson LJ, van der Giessen JW, Batz MB, Kojima M, Cahill S (2013) Have foodborne parasites finally become a global concern? Trends Parasitol 29:101–103
3. Gómez-Marin J, de-la-Torre A, Angel-Muller E, Rubio J et al (2011) First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis 5(5):e1195
4. Fatoohi AF, Cozon GJ, Greenland T, Ferrandiz J, Bienvenu J, Picot S, Peyron F (2002) Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. Clin Diagn Lab Immunol 9:704–707
5. Mendes ÉA, Fonseca FG, Casério BM, Colina JP, Gazzinelli RT, Caetano BC (2013) Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1. PLoS One 8(5):e63201
6. Siachoque H, Guzman F, Burgos J, Patarroyo ME, Gomez-Marin JE (2006) Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp Parasitol 114:62–65
7. Tao Q, Fang R, Zhang W, Wang Y, Cheng J, Li Y, Fang K, Khan MK, Hu M, Zhou Y, Zhao J (2013) Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. Parasitol Res 112:2871–2877
8. Qu D, Han J, Du A (2013) Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitol Res 112:2593–2599
9. Sepulveda-Arias JC, Kempf MC, Wiehr S, Wedekind D, Hedrich HJ, Gross U, Herrmann T (2008) Control of Toxoplasma gondii infection by athymic LEW-Whn rnu rats. Parasite Immunol 30:323–333
10. Feliu V, Vasseur V, Grover HS, Chu HH, Brown MJ, Wang J, Boyle JP, Robey EA, Shastri N, Blanchard N (2013) Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite. PLoS Pathog 9(6):e1003449
11. Tan TG, Mui E, Cong H et al (2010) Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine 28:3977–3989
12. Cong H, Mui EJ, Witola WH et al (2012) Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-gamma and reduces parasite burden in HLA-B*0702 mice. Human Immunol 73:1–10
13. de-la-Torre A, Lopez-Castillo C, Gomez-Marin JE (2009) Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye 23:1090–1093
14. Cardona N, de-la-Torre A, Siachoque H, Patarroyo MA, Gomez-Marin JE (2009) Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis. Exp Parasitol 123:199–202
15. Taylor S, Barragan A, Su C et al (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314:1776–1780
16. Kahi S, Cozon GJN, Greenland T, Wallon M, Gay-Andrieu F, Peyron F (1998) Rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans. Clin Diag Lab Immunol 5:745–748
17. Fatoohi F, Cozon GJ, Wallon M, Kodjikian L, Peyron F (2006) Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis. Jpn J Ophthalmol 50:103–110
18. de-la-Torre A, Sauer A, Bourcier T, Speeg-Schatz C, Ballonzoli L, Ajzenberg D, Sundar N, Grigg ME, Villard O, Brunet J, Pfaff A, Gomez-Marin J, Candolfi E (2013) Severe Southamerican ocular toxoplasmosis is associated with decreased IFN-gamma/IL-17A and increased IL-6/IL-13 intraocular levels. PLoS Neglected Trop Dis 7(11):e2541. doi:10.1371/journal.pntd.0002541
19. Gallego C, Saavedra-Matiz C, Gómez-Marín JE (2006) Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America). Acta Trop 97:161–167
20. Sánchez V, de-la-Torre A, Gómez Marín JE (2014) Characterization of ROP18 alleles in human toxoplasmosis. Parasitol Int 63:463–469
21. Morisset S, Peyron F, Lobry JR et al (2008) Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect 10:742–747
22. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC (2007) Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445:324–327
23. Kahi S, Cozon GJ, Pinon JM et al (1999) A switch towards Th2 during serological rebound in children with congenital toxoplasmosis. Clin Exp Immunol 117:524–528
24. McLeod R, Mack DG, Boyer K et al (1990) Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med 116:623–635
25. D’Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041–1048
26. Kato M, Claveria FG, Maki Y et al (2007) Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies. Pathobiology 74:50–56